Alport Connect 2023, the annual Alport syndrome patient and family meeting in US

7-8 October, 2023
San Diego, CA

ENYO Pharma is sponsoring and will attend Alport Connect 2023 organized by the American Alport Syndrome Foundation (ASF) to meet patients and their family and present its Phase 2 clinical study planned with Vonafexor in Alport syndrome patients.

Alport Connect Meetings

Read more »

60th ERA congress, the Annual Nephrology Congress in Europe

15-18 June 2023
Milan, Italy

ENYO Pharma will attend and present at 60th ERA congress, the Annual Nephrology Congress in Europe

Read more »

5th CKD Summit – Chronic Kidney Disease Drug Development

7-9 March, 2023
Boston, MA

ENYO was attending the 5th Chronic Kidney Disease Drug Development Summit, an industry forum sharing cross-industry insight to bring effective therapies to patients suffering from kidney diseases expanding also to rare renal disorders.

Read more »

ASN Kidney Week

3-6 November 2022
Orlando, FL

ENYO Pharma was attending the world’s premier nephrology meeting of the American Society of Nephrology, ASN Kidney Week

Read more »

2022 International HBV Meeting

18-22 September, 2022
Paris, France.

ENYO Pharma sponsored and attent the 2022 International HBV Meeting on 18-22 September, 2022 organized by our collaborator Dr. David Durantel, Director of Research in Infectiology and team leader at the International Center for Research in Infectiology (CIRI-INSERM), Lyon, France.

Read more »